On this page
USP9X
ubiquitin specific peptidase 9 X-linked
USP9X encodes a deubiquitinating enzyme on the X chromosome that regulates protein stability and cellular signalling, with pathogenic variants associated with neurodevelopmental conditions. The USP9X gene provides instructions for making an enzyme that removes ubiquitin tags from proteins, thereby influencing their lifespan and activity within cells.
USP9X is located on the short (p) arm of chromosome X, at band Xp11.4. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
USP9X encodes ubiquitin specific peptidase 9 X-linked, a member of the deubiquitinating enzyme family that removes ubiquitin molecules from target proteins. This process is essential for controlling protein degradation and modulating signal transduction pathways during development and throughout life. The gene is located on the X chromosome, meaning that inheritance follows an X-linked pattern in which males typically exhibit more severe manifestations when a pathogenic variant is present. Loss-of-function variants in USP9X are recognized causes of a range of neurodevelopmental features, including intellectual disability, structural brain anomalies, and congenital malformations affecting multiple organ systems.
What the gene does
The USP9X protein functions as a deubiquitinating enzyme, catalysing the removal of ubiquitin from substrate proteins and thereby preventing their targeted degradation by the proteasome. By stabilising or destabilising specific proteins, USP9X influences cellular processes such as signal transduction, cell cycle progression, and neuronal development. Research suggests the enzyme participates in pathways that regulate synaptic function and neural circuit formation, which are critical for normal cognitive development. The protein's activity is particularly important in the developing brain, where precise control of protein turnover ensures appropriate timing of developmental milestones. Disruption of USP9X-mediated deubiquitination can impair the balance of signalling molecules required for neurogenesis and synaptogenesis, contributing to the neurodevelopmental phenotypes observed in affected individuals.
Video: Genetics 101
Chromosome location
USP9X is located at chromosomal band Xp11.4 on the short arm of the X chromosome. The gene spans a substantial genomic region and comprises multiple exons that together encode a large protein of 2554 amino acids. Its position on the X chromosome means that males, who have only one X chromosome, are hemizygous for USP9X and therefore more vulnerable to the effects of loss-of-function variants. Females carry two copies of the X chromosome, and X-inactivation patterns can influence the clinical presentation when a pathogenic variant is present on one allele.
Protein structure
The USP9X protein is 2554 amino acids in length and contains several structurally distinct regions. Studies indicate disordered regions are present at amino acids 1-65, 967-999, 1592-1621, and 2475-2554, which may facilitate flexible interactions with binding partners and regulatory proteins. The catalytic USP domain spans amino acids 1557-1956 and is responsible for the enzyme's deubiquitinating activity, harbouring the active-site residues that cleave ubiquitin-protein bonds. The extended disordered segments flanking and interspersed with the catalytic core are thought to contribute to substrate recognition and regulation of enzymatic function, allowing USP9X to engage diverse protein targets in different cellular contexts.
Key variants
Pathogenic variants in USP9X include loss-of-function changes such as nonsense mutations, frameshift insertions or deletions, and splice-site alterations that disrupt protein production or catalytic activity. Missense variants affecting the USP domain can impair the enzyme's ability to remove ubiquitin tags, leading to aberrant protein degradation and signalling defects. The variant landscape reflects the gene's X-linked inheritance, with males more commonly presenting with severe phenotypes due to hemizygosity.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1774C>T | p.Arg592Ter | Pathogenic | ★★☆☆ | Intellectual disability, X-linked 99, syndromic, female-restricted |
c.1812_1815del | p.Gln605fs | Pathogenic | ★★☆☆ | Intellectual disability, X-linked 99, syndromic, female-restricted |
c.2746C>T | p.Arg916Ter | Pathogenic | ★★☆☆ | Intellectual disability, X-linked 99, syndromic, female-restricted |
c.323-1G>A | - | Pathogenic/Likely pathogenic | ★★☆☆ | Intellectual disability, X-linked 99, syndromic, female-restricted |
c.6254G>A | p.Arg2085His | Pathogenic/Likely pathogenic | ★★☆☆ | Intellectual disability, X-linked 99 |
c.7096C>T | p.Arg2366Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Intellectual disability, X-linked 99, syndromic, female-restricted |
c.82dup | p.Leu28fs | Pathogenic | ★★☆☆ | Inborn genetic diseases |
g.(?_41165872)_(41167577_?)del | - | Pathogenic | ★☆☆☆ | not provided |
c.1140G>A | p.Trp380Ter | Pathogenic | ★☆☆☆ | not provided |
c.1201C>T | p.Arg401Ter | Pathogenic | ★☆☆☆ | not provided |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in USP9X are associated with a spectrum of neurodevelopmental and congenital conditions. Affected individuals may present with intellectual disability ranging from mild to severe, with males typically more severely affected due to X-linked inheritance, often accompanied by speech and motor delays. Structural brain anomalies such as hydrocephalus and corpus callosum abnormalities have been reported. Additional features can include facial clefting, choanal atresia, limb malformations, and pigmentary skin changes, reflecting the broad role of USP9X in developmental processes across multiple organ systems.
No disease links recorded for this gene in our reference set.
Inheritance pattern
Conditions caused by pathogenic USP9X variants typically follow x-linked inheritance.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
UK clinical status
USP9X is included on multiple NHS Genomic Medicine Service gene panels, reflecting its clinical relevance in diagnosing neurodevelopmental and congenital disorders. The gene holds green (diagnostic-grade-meaning high-quality evidence supports clinical testing) status on panels for choanal atresia, clefting, intellectual disability, hydrocephalus, limb disorders, pigmentary skin disorders, foetal anomalies, and the Developmental Disorders Genotype-to-Phenotype (DDG2P) dataset. This broad panel representation underscores the diverse clinical presentations associated with USP9X variants and supports its inclusion in diagnostic sequencing for individuals with overlapping developmental features. Testing is typically accessed through clinical genetics or paediatric neurology services via the NHS Genomic Medicine Service.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Diet & lifestyle considerations
No specific lifestyle modifications are known to influence the effects of USP9X variants. Management focuses on supportive care tailored to individual developmental needs.
Supplement considerations
No specific dietary supplements have been shown to modify outcomes associated with USP9X variants.
Frequently asked questions
How is USP9X inherited?
USP9X follows an X-linked inheritance pattern. Males, who have one X chromosome, are typically more severely affected by pathogenic variants, whereas females may exhibit variable features depending on X-inactivation patterns.
What does the USP9X protein do?
The USP9X protein removes ubiquitin molecules from other proteins, preventing their degradation and thereby regulating cellular signalling and development. This activity is particularly important in the developing brain.
Why is USP9X included on multiple NHS gene panels?
USP9X variants are associated with a wide range of developmental features, including intellectual disability, brain anomalies, facial clefting, and limb defects. Its inclusion on multiple panels reflects the diverse clinical presentations seen in affected individuals.